Literature DB >> 28574868

Evaluation of completeness of case ascertainment in Swiss cancer registration.

Matthias Lorez1, Andrea Bordoni, Christine Bouchardy, Jean-Luc Bulliard, Bertrand Camey, Silvia Dehler, Harald Frick, Isabelle Konzelmann, Manuela Maspoli, Seyed M Mousavi, Sabine Rohrmann, Volker Arndt.   

Abstract

This is the first comprehensive evaluation of completeness of case ascertainment in Swiss cancer registration. There is currently no method available that is considered to be the gold standard. Apart from simple measures such as the proportion of cases where registration was initiated by a death certificate and the proportion of diagnoses on the basis of histology or cytology/haematology, we applied two dedicated approaches: (i) the semiquantitative method of comparing the mortality to incidence rate ratio with relative survival (MI-Surv method) and (ii) the Flow method, which provides a quantitative estimate for the completeness depending on time since diagnosis. All 10 Swiss cancer registries in operation since at least 2006 and providing the required parameters were included. Simple and dedicated methods showed high completeness across all cancer registries and for most cancer types tested, with the notable exception of lymphoid leukaemia.

Entities:  

Mesh:

Year:  2017        PMID: 28574868     DOI: 10.1097/CEJ.0000000000000380

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  14 in total

1.  Quality indicators of clinical cancer care for prostate cancer: a population-based study in southern Switzerland.

Authors:  Laura Ortelli; Alessandra Spitale; Luca Mazzucchelli; Andrea Bordoni
Journal:  BMC Cancer       Date:  2018-07-11       Impact factor: 4.430

2.  Ascertainment of cancer in longitudinal research: The concordance between the Rotterdam Study and the Netherlands Cancer Registry.

Authors:  Kimberly D van der Willik; Rikje Ruiter; Frank J A van Rooij; Jolande Verkroost-van Heemst; Sander J Hogewoning; Karin C A A Timmermans; Otto Visser; Sanne B Schagen; M Arfan Ikram; Bruno H Ch Stricker
Journal:  Int J Cancer       Date:  2019-11-07       Impact factor: 7.396

3.  Estimating lifetime and 10-year risk of lung cancer.

Authors:  Christina Bruder; Jean-Luc Bulliard; Simon Germann; Isabelle Konzelmann; Murielle Bochud; Magali Leyvraz; Arnaud Chiolero
Journal:  Prev Med Rep       Date:  2018-06-18

4.  Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment?

Authors:  Sabrina Jegerlehner; Arnaud Chiolero; Drahomir Aujesky; Nicolas Rodondi; Simon Germann; Isabelle Konzelmann; Jean-Luc Bulliard
Journal:  PLoS One       Date:  2019-02-04       Impact factor: 3.240

5.  Semen quality of young men in Switzerland: a nationwide cross-sectional population-based study.

Authors:  R Rahban; L Priskorn; A Senn; E Stettler; F Galli; J Vargas; M Van den Bergh; A Fusconi; R Garlantezec; T K Jensen; L Multigner; N E Skakkebaek; M Germond; N Jørgensen; S Nef
Journal:  Andrology       Date:  2019-05-21       Impact factor: 3.842

6.  Worldwide Trends in Survival From Common Childhood Brain Tumors: A Systematic Review.

Authors:  Fabio Girardi; Claudia Allemani; Michel P Coleman
Journal:  J Glob Oncol       Date:  2019-10

7.  Incidence Trends of Cervical Cancer and Its Precancerous Lesions in Women of Central Switzerland from 2000 until 2014.

Authors:  Katrin Ochs; Gesine Meili; Joachim Diebold; Volker Arndt; Andreas Günthert
Journal:  Front Med (Lausanne)       Date:  2018-03-16

Review 8.  Indicators of Data Quality at the Cancer Registry Zurich and Zug in Switzerland.

Authors:  Miriam Wanner; Katarina L Matthes; Dimitri Korol; Silvia Dehler; Sabine Rohrmann
Journal:  Biomed Res Int       Date:  2018-06-13       Impact factor: 3.411

9.  The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.

Authors:  Anita Feller; Katarina L Matthes; Andrea Bordoni; Christine Bouchardy; Jean-Luc Bulliard; Christian Herrmann; Isabelle Konzelmann; Manuela Maspoli; Mohsen Mousavi; Sabine Rohrmann; Katharina Staehelin; Volker Arndt
Journal:  BMC Cancer       Date:  2020-01-21       Impact factor: 4.430

10.  Geographical variation in malignant and benign/borderline brain and CNS tumor incidence: a comparison between a high-income and a middle-income country.

Authors:  Miriam Wanner; Sabine Rohrmann; Dimitri Korol; Nino Shenglia; Teimuraz Gigineishvili; David Gigineishvili
Journal:  J Neurooncol       Date:  2020-08-19       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.